Intercept Pharmaceuticals

Intercept Pharmaceuticals (ICPT) is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat chronic liver disease utilizing its proprietary bile acid chemistry. This stock closed up 8.6% at $62.87 in Fridays trading session.

Friday's Volume: 891,000
Three-Month Average Volume: 196,239
Volume % Change: 455%

>>5 Stocks With Big Insider Buying

From a technical perspective, ICPT spiked sharply higher here right above its 50-day moving average of $55.19 with heavy upside volume. This move briefly pushed shares of ICPT into breakout territory, after the stock took out some near-term overhead resistance at $63.20. Shares of ICPT closed just below that breakout level at $62.87. Market players should now look for a continuation move higher in the short-term if ICPT manages to take out Friday's intraday high of $63.58 with high volume.

Traders should now look for long-biased trades in ICPT as long as it's trending above $60, and then once it sustains a move or close above $63.58 with volume thats near or above 196,239 shares. If we get that move soon, then ICPT will set up to re-test or possibly take out its next major overhead resistance levels at $70 to $72.

If you liked this article you might like

Biotech 2013 by the Numbers: A Blockbuster Year

3 Health Care Stocks Spiking on Big Volume

Trade-Ideas: Gentium SpA (GENT) Is Today's New Lifetime High Stock

4 Stocks Triggering Breakout Trades